New injection tested for people with uncontrolled chronic hives
NCT ID NCT07166211
Summary
This study is testing an investigational injection called CM512 to see if it can reduce the severity of hives and itching in adults with chronic spontaneous urticaria (CSU) who still have symptoms despite taking standard allergy medications. About 48 participants will be randomly assigned to receive either the CM512 injection or a placebo (dummy) injection, and neither they nor the doctors will know which one they get. The main goal is to measure the change in a weekly hives and itch activity score after 16 weeks of treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC SPONTANEOUS URTICARIA (CSU) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Tianjin Academy of Traditional Chinese Medicine Affiliate Hospital
Tianjin, Tianjin Municipality, China
Conditions
Explore the condition pages connected to this study.